RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
Hats off to the Brazilian team. Unfortuntaley, no evidence of benefit for HCQ. "The first patient underwent randomization on 3/29/20; the last patient underwent randomization on 5/17/20" https://t.co/OAFEJ5ifJc
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @dr_michaelmarks: HCQ +/- Azithro no impact mild-moderate #COVID19 @NEJM https://t.co/Ab8vfHJUFY Its almost as if the drug doesn't work.…
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
Et ça continue, et c’est brésilien : Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/3i4vi0rr61
RCT from Brazil: hydroxychloroquine, alone or with azithromycin patients smog hospitalized with mild-to-moderate #COVID19 did not improve clinical status at 15 days as compared with standard care. https://t.co/UXefmJuAti
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
Just published in #NEJM in 23,July. An RCT from Brazil on #hydroxychloroquine. Among patients hospitalized with mild-to-moderate #covid19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status https://t.co/qKLuQGGMu7
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
CONCLUSIONS Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, DID NOT IMPROVE clinical status at 15 days as compared with standard care.
There we go. https://t.co/pYoe3kYqgS
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
RT @mtmdphd: Hydroxychloroquine +/- Azithromycin in Mild-to-Moderate Covid-19 [Jul 23, 2020] Cavalcanti et al. @NEJM https://t.co/GUM6OwRG6…
RT @PauloLotufo: Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alg…
RT @DrChoueiri: Just NOW in @NEJM —another RCT of #HCQ this time from Brazil showing no benefit in #COVID19 (with minimal O2 req) https://t…
RT @DrChoueiri: Just NOW in @NEJM —another RCT of #HCQ this time from Brazil showing no benefit in #COVID19 (with minimal O2 req) https://t…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
@raoult_didier Stop SVP. Vous faites du mal au monde entier. Maintenant que vous savez que vous aviez tort, il est vraiment temps de l'admettre et de laisser le monde passer à autre chose. Une nouvelle étude randomisée dans le NEJM vous contredit à nouveau
Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina TAMPOCO funciona si se administra junto al antibiótico azimotricina. En el New England Journal of Medicine: https://t.co/is7VoPTpF
NEJM: "Among patients hospitalized with mild-to-moderate #COVID19 19, the use of #hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care." https://t.co/NzD0E9E48W
@raoult_didier Tenez vous êtes cité la dedans aussi. Mais c'est pas glorieux pour vous. https://t.co/RL5t27t7fr
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/HhcZLHenQN
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @texhern: Another important example of doing a rigorous randomized trial Thx to the people in Brazil @RenatoDLopes1 Hydroxychloroq…
Olhaí.
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/Eoz1jwInsw
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
Just out in @NEJM. Another negative HCQ trial for #COVID, even in mild disease, & a potential for harm. Soo we probably can stop now? Good job investigators! 👀 @leticiakawano Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid
RT @besteves: mais uma evidência de que a hidroxicloroquina não é eficaz em pacientes com quadros leves ou moderados de covid-19, combinada…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @ProOpenmind2020: Une RCT de plus qui discrédite Raoult HCQ+AZT ! Manque rien "Mild to moderate Covid" ! Donc on peut pas dire que ce so…
RT @mtmdphd: Hydroxychloroquine +/- Azithromycin in Mild-to-Moderate Covid-19 [Jul 23, 2020] Cavalcanti et al. @NEJM https://t.co/GUM6OwRG6…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate #Covid_19 | NEJM https://t.co/GUOD8i240h
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
mais uma evidência de que a hidroxicloroquina não é eficaz em pacientes com quadros leves ou moderados de covid-19, combinada com azitromicina ou não. desta vez vinda de um estudo randomizado brasileiro publicado numa das bíblias da literatura médica, o NE
RT @matthewherper: NEJM just posted a randomized controlled trial of hydroxychloroquine, hydroxychloroquine and azithromycin, or standard o…
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @RonChusid: Hydroxychloroquine fails to help in yet another study, this time in mild to moderate cases. https://t.co/4fdVYM30OM
RT @texhern: Another important example of doing a rigorous randomized trial Thx to the people in Brazil @RenatoDLopes1 Hydroxychloroq…
See? This is how it should be done. Instead of giving lots of crazy stuff to patients with a novel disease (AKA #COVID19) you design one hell of a trial and randomize patients. Congrats Brazilian friends!
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
Hydroxychloroquine fails to help in yet another study, this time in mild to moderate cases. https://t.co/4fdVYM30OM
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
What's the Portuguese word for zinc 🤪 #COVIDIOTS
Olha outra surpresa do nível da do Cavani. https://t.co/Gkq6L7snwZ
Another important example of doing a rigorous randomized trial Thx to the people in Brazil @RenatoDLopes1 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/iQW7yX16Q1
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
Une RCT de plus qui discrédite Raoult HCQ+AZT ! Manque rien "Mild to moderate Covid" ! Donc on peut pas dire que ce sont des cas tp graves. Et l'étude vient du Brésil, un pays où Bolso ferait n'importe quoi pour vendre l'HCQ à ses détracteurs ! Même si ça
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
Teknik bir soru: Türkiye’de #HCQ içeren tedavi protokollerinin #EtikKurul onayı öncesinde hastalar sigortalandılar mı? #COVID19 #BilimKurulu #bilimselaraştırma #EtikKurul #NEJM Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 h
RT @PauloLotufo: Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alg…
Brazilian 🇧🇷 multicenter RCT looking at HCQ just published in NEJM.
RT @PauloLotufo: Brasil chuta a cloroquina. Parabéns, aos meus seguidores @f_g_zampieri @leticiakawano pela publicação e pelo sigilo mantid…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @lavieri: Infelizmente, não vai mudar nada para os cloroquiners. Vão dizer que não adianta para hospitalizados, mas apenas para quem est…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @CMichaelGibson: Among patients hospitalized with mild-to-moderate #Covid19, the use of hydroxychloroquine, alone or with azithromycin,…
Nouvelle étude NEJM sur HCQ : Ça progresse, et toujours vers + de "bah non ça marche pas". Il serait peut-être temps de passer à autre chose plutôt que de cramer les budgets de la recherche et le temps des chercheurs dans cette voie inutile.
Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e institutos de pesquisa. Não foi demonstrado efeito benéfico algum e mais eventos adversos em doentes hospitalizados.
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alguns foram meus alunos ou residentes Devem ter assistido a alguma aula de epidemiologia clínica, depois viraram "feras em ensaios clín
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
Attention off-label Covid-19 treatment enthusiasts: "Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care." https
Among patients hospitalized with mild-to-moderate #Covid19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care. NEJM https://t.co/vTah6DD3Ev
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…